ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

Benzinga • Aug 7, 2026

ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript

ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

ICU Medical Q2 Earnings Call Highlights

ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.

MarketBeat • Aug 7, 2026

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.

GlobeNewsWire • Aug 6, 2026

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Aug 7, 2026

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.

Zacks Investment Research • Aug 7, 2026

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.

GlobeNewsWire • Jul 23, 2026

Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America

This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support portfolio development and advance non-DEHP innovation for the North American IV solutions market. Joint venture announces over $500M IV solutions manufacturing expansion in Austin, TX Expansion aimed at improving IV solutions supply resiliency and quality, and accelerating non-DEHP new product development in North America via fully automated technology First major milestone toward fulfilling the commitments of the joint venture finalized in May 2025 between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc. AUSTIN, Texas, July 9, 2026 /PRNewswire/ -- Otsuka ICU Medical LLC today announced plans for an over $500 million expansion to its US IV solutions manufacturing through a new facility and significant upgrades to its existing operations in Austin, Texas.

PRNewsWire • Jul 9, 2026

ICUI vs. SYK: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Jul 8, 2026

ICUI or MDLN: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Medline (MDLN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jun 18, 2026